Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Positive phase II results reported for platelet substitute

Jan. 24, 1997

Additional beneficial lipid-modifying effects of FCP-3P1 reported

Jan. 24, 1997

Cerebrus discovers role of gene in obesity

Jan. 24, 1997

Inhibitors of alpha-amylase disclosed by Japanese researchers

Jan. 23, 1997

ACAT inhibitors from Takeda

Jan. 23, 1997

NESP enters clinical trials

Jan. 22, 1997

Ergo readying first NDA submission

Jan. 22, 1997

Research supports development of Houghten lead compound

Jan. 22, 1997

Asta seeks rights to impotency Rx

Jan. 21, 1997

First market introductions for Bondronat

Jan. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026